NM_003194.5:c.231delG

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_003194.5(TBP):​c.231delG​(p.Gln77HisfsTer67) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.093 in 1,036,150 control chromosomes in the GnomAD database, including 3,499 homozygotes. Variant has been reported in ClinVar as Likely benign (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.14 ( 1707 hom., cov: 27)
Exomes 𝑓: 0.086 ( 1792 hom. )

Consequence

TBP
NM_003194.5 frameshift

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 2.39

Publications

7 publications found
Variant links:
Genes affected
TBP (HGNC:11588): (TATA-box binding protein) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes TBP, the TATA-binding protein. A distinctive feature of TBP is a long string of glutamines in the N-terminus. This region of the protein modulates the DNA binding activity of the C terminus, and modulation of DNA binding affects the rate of transcription complex formation and initiation of transcription. The number of CAG repeats encoding the polyglutamine tract is usually 25-42, and expansion of the number of repeats to 45-66 increases the length of the polyglutamine string and is associated with spinocerebellar ataxia 17, a neurodegenerative disorder classified as a polyglutamine disease. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2016]
TBP Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 17
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 6-170561966-AG-A is Benign according to our data. Variant chr6-170561966-AG-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 3065444.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.474 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003194.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBP
NM_003194.5
MANE Select
c.231delGp.Gln77HisfsTer67
frameshift
Exon 3 of 8NP_003185.1P20226-1
TBP
NM_001172085.2
c.171delGp.Gln57HisfsTer67
frameshift
Exon 2 of 7NP_001165556.1P20226-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBP
ENST00000392092.7
TSL:1 MANE Select
c.231delGp.Gln77HisfsTer67
frameshift
Exon 3 of 8ENSP00000375942.2P20226-1
TBP
ENST00000230354.10
TSL:1
c.231delGp.Gln77HisfsTer67
frameshift
Exon 3 of 8ENSP00000230354.5P20226-1
TBP
ENST00000421512.5
TSL:1
c.231delGp.Gln77HisfsTer67
frameshift
Exon 3 of 5ENSP00000400008.1Q7Z6S5

Frequencies

GnomAD3 genomes
AF:
0.136
AC:
19073
AN:
139944
Hom.:
1705
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.0913
Gnomad AMI
AF:
0.210
Gnomad AMR
AF:
0.131
Gnomad ASJ
AF:
0.188
Gnomad EAS
AF:
0.492
Gnomad SAS
AF:
0.203
Gnomad FIN
AF:
0.0590
Gnomad MID
AF:
0.129
Gnomad NFE
AF:
0.143
Gnomad OTH
AF:
0.146
GnomAD2 exomes
AF:
0.0227
AC:
4178
AN:
184244
AF XY:
0.0210
show subpopulations
Gnomad AFR exome
AF:
0.0241
Gnomad AMR exome
AF:
0.0214
Gnomad ASJ exome
AF:
0.0115
Gnomad EAS exome
AF:
0.158
Gnomad FIN exome
AF:
0.00512
Gnomad NFE exome
AF:
0.0120
Gnomad OTH exome
AF:
0.0241
GnomAD4 exome
AF:
0.0863
AC:
77293
AN:
896102
Hom.:
1792
Cov.:
0
AF XY:
0.0931
AC XY:
41824
AN XY:
449306
show subpopulations
African (AFR)
AF:
0.0581
AC:
1202
AN:
20698
American (AMR)
AF:
0.122
AC:
2983
AN:
24360
Ashkenazi Jewish (ASJ)
AF:
0.141
AC:
2442
AN:
17302
East Asian (EAS)
AF:
0.447
AC:
13961
AN:
31210
South Asian (SAS)
AF:
0.178
AC:
9966
AN:
56006
European-Finnish (FIN)
AF:
0.0695
AC:
2226
AN:
32008
Middle Eastern (MID)
AF:
0.111
AC:
444
AN:
4002
European-Non Finnish (NFE)
AF:
0.0592
AC:
39736
AN:
671260
Other (OTH)
AF:
0.110
AC:
4333
AN:
39256
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.409
Heterozygous variant carriers
0
3918
7835
11753
15670
19588
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
364
728
1092
1456
1820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.136
AC:
19091
AN:
140048
Hom.:
1707
Cov.:
27
AF XY:
0.132
AC XY:
8978
AN XY:
68012
show subpopulations
African (AFR)
AF:
0.0914
AC:
3341
AN:
36570
American (AMR)
AF:
0.131
AC:
1880
AN:
14356
Ashkenazi Jewish (ASJ)
AF:
0.188
AC:
621
AN:
3302
East Asian (EAS)
AF:
0.492
AC:
2162
AN:
4398
South Asian (SAS)
AF:
0.202
AC:
850
AN:
4204
European-Finnish (FIN)
AF:
0.0590
AC:
594
AN:
10064
Middle Eastern (MID)
AF:
0.129
AC:
36
AN:
280
European-Non Finnish (NFE)
AF:
0.143
AC:
9137
AN:
64088
Other (OTH)
AF:
0.150
AC:
291
AN:
1934
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.408
Heterozygous variant carriers
0
560
1120
1681
2241
2801
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
212
424
636
848
1060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0466
Hom.:
36

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
-
-
1
not specified (1)
-
-
1
Spinocerebellar ataxia type 17 (1)
-
-
-
Parkinson disease, late-onset (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.4
Mutation Taster
=199/1
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs770128377; hg19: chr6-170871054; COSMIC: COSV57830658; API